Published in Br J Ophthalmol on July 01, 2001
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet (1995) 17.27
Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature (1994) 9.06
Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology (1999) 5.34
Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol (1999) 2.37
High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med (1998) 2.30
Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol (1994) 2.15
Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology (2000) 2.12
Risk factors for retinal vein occlusions. A case-control study. Ophthalmology (1992) 2.06
Inherited thrombophilia: Part 1. Thromb Haemost (1996) 2.00
The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med (1999) 1.97
Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost (1998) 1.71
Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin Hematol (1997) 1.68
Hyperhomocysteinaemia in young patients with non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol (1999) 1.65
Activated protein C and retinal vein occlusion. Br J Ophthalmol (1996) 1.47
Central retinal vein occlusion in young adults. Surv Ophthalmol (1993) 1.44
Anterior ischemic optic neuropathy: trouble waiting to happen. Ophthalmology (1999) 1.44
Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential risk factors. Arch Ophthalmol (1997) 1.40
Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol (1993) 1.33
Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol (1996) 1.33
Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol (1996) 1.29
The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology (1990) 1.19
Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations. Am J Ophthalmol (1997) 1.13
The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost (1998) 1.13
Arterial vascular occlusion associated with factor V Leiden gene mutation. Retina (1998) 1.11
Peripheral retinal neovascularization and retinal vascular occlusion associated with activated protein C resistance. Am J Ophthalmol (1997) 1.10
Retinal artery occlusion. Surv Ophthalmol (1996) 1.08
Factor V Leiden mutation is associated with ocular involvement in Behçet disease. Am J Ophthalmol (1999) 1.06
Preventing coronary heart disease: B vitamins and homocysteine. Circulation (1998) 1.04
Familial thrombophilia and retinal vein occlusion. Eye (Lond) (2000) 1.04
Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion. Acta Ophthalmol Scand (2000) 1.00
The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost (1997) 1.00
Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening, and treatment. off. Arch Intern Med (1998) 0.96
Central retinal vein thrombosis associated with resistance to activated protein C. Am J Ophthalmol (1995) 0.95
Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation. Ophthalmology (1999) 0.91
Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion. Arch Ophthalmol (1999) 0.90
Bilateral retinal vein occlusion associated with 5,10-methylenetetrahydrofolate reductase mutation. Am J Ophthalmol (1997) 0.89
Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults. Arch Ophthalmol (1998) 0.89
Hypercoagulability and high lipoprotein(a) levels in patients with central retinal vein occlusion. Thromb Haemost (1994) 0.88
Factor V Leiden mutation in patients with Behçet's disease. J Rheumatol (1998) 0.88
Venous thrombosis--the interaction of genes and environment. N Engl J Med (1998) 0.87
Anterior ischemic optic neuropathy and activated protein C resistance. A case report and review of the literature. J Neuroophthalmol (1997) 0.87
Association of factor V Leiden with Behçet's disease. J Rheumatol (1997) 0.86
Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation. Am J Ophthalmol (2000) 0.86
Activated protein C resistance in patients with central retinal vein occlusion. Br J Ophthalmol (1997) 0.86
Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factors. Ophthalmology (1994) 0.85
Branch retinal arteriolar occlusion associated with familial factor V Leiden polymorphism and positive rheumatoid factor. Arch Ophthalmol (1999) 0.85
Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thromb Haemost (1998) 0.84
Retinal vein occlusion and inherited conditions predisposing to thrombophilia. Thromb Haemost (1998) 0.84
Homocysteine--a novel risk factor for vascular disease. J R Soc Med (2001) 0.83
Activated protein C resistance--low incidence in glaucomatous optic disc haemorrhage and central retinal vein occlusion. Aust N Z J Ophthalmol (1996) 0.82
Is non-arteritic anterior ischaemic optic neuropathy related to homocysteine? Br J Ophthalmol (2000) 0.81
Thermolabile MTHFR genotype and retinal vascular occlusive disease. Br J Ophthalmol (2001) 0.81
Thrombophilia. Curr Opin Hematol (1999) 0.80
Role of rheologic factors in patients with acute central retinal vein occlusion. Ophthalmology (1996) 0.80
Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion. Eye (Lond) (1995) 0.79
The modified APC resistance test in the presence of factor V deficient plasma can be used in patients without oral anticoagulant. Thromb Haemost (1996) 0.78
A 5-nucleotide insertion in the antithrombin gene causing a quantitative antithrombin deficiency. Thromb Haemost (1997) 0.78
Bilateral retinal vein occlusion associated with factor V Leiden mutation. Retina (1998) 0.77
Screening for resistance to activated protein C and the mutant gene for factor V:Q506 in patients with central retinal vein occlusion. Am J Ophthalmol (1997) 0.77
Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol (2000) 0.76
Idiopathic central retinal vein occlusion in a thrombophilic patient with the heterozygous 20210 G/A prothrombin genotype. Am J Ophthalmol (1999) 0.76
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
Chronic relapsing inflammatory optic neuropathy (CRION). Brain (2003) 2.83
Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology (2001) 2.61
Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet (1996) 2.12
Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens (1999) 2.02
Systemic corticosteroid therapy--side effects and their management. Br J Ophthalmol (1998) 1.81
Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology (2000) 1.75
Early Neurodegeneration after Hypoxia-Ischemia in Neonatal Rat Is Necrosis while Delayed Neuronal Death Is Apoptosis. Neurobiol Dis (2001) 1.72
Questioning questionnaires. Eye (Lond) (2001) 1.58
Relationship of diabetic microvascular complications to outcome in panretinal photocoagulation treatment of proliferative diabetic retinopathy. Eye (Lond) (1997) 1.58
Immune exclusion and mucus trapping during the rapid expulsion of Nippostrongylus brasiliensis from primed rats. Immunology (1981) 1.56
Cytokines in human intraocular inflammation. Curr Eye Res (1992) 1.44
Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect (1999) 1.42
Intraocular tuberculosis. Eye (Lond) (1990) 1.42
Ocular changes in limited forms of Wegener's granulomatosis. Br J Ophthalmol (1981) 1.39
Radioiodine and Graves' ophthalmopathy reconsidered. Nucl Med Commun (2001) 1.39
The ocular complications of HIV and AIDS. Int J STD AIDS (1997) 1.38
Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol (2000) 1.36
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 1.32
Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol (2003) 1.30
Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol (2000) 1.26
Electrophysiological characterisation and monitoring in the management of birdshot chorioretinopathy. Br J Ophthalmol (2005) 1.18
Late onset Leber's optic neuropathy: a case confused with ischaemic optic neuropathy. Br J Ophthalmol (1992) 1.14
Choroidal hypoperfusion in acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiography study. Ophthalmology (1995) 1.13
A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol (1989) 1.12
Visual loss and falls: a review. Eye (Lond) (2010) 1.11
HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease. Tissue Antigens (1999) 1.10
Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth. BMJ (1995) 1.09
Cyclosporin A in the treatment of posterior uveitis. Trans Ophthalmol Soc U K (1985) 1.08
Surgical treatment of superior bullous rhegmatogenous retinal detachments. Br J Ophthalmol (1985) 1.08
Optic neuropathy in sarcoidosis. J Neurol Neurosurg Psychiatry (1986) 1.07
Factor V Leiden mutation is associated with ocular involvement in Behçet disease. Am J Ophthalmol (1999) 1.06
Metastatic choriocarcinoma presenting as multiple intracerebral haemorrhages: the role of imaging in the elucidation of the pathology. J Neurol Neurosurg Psychiatry (1998) 1.04
A British ophthalmological surveillance unit. British Ophthalmological Surveillance Unit Steering Committee. Br J Ophthalmol (1997) 1.01
The stimulation of IL-2 production by anti-rheumatic drugs. Immunology (1989) 1.00
Acute retinal necrosis in children caused by herpes simplex virus. Retina (2001) 0.98
Recognition of B-cell epitopes of the 65 kDa HSP in Behçet's disease. Scand J Immunol (1996) 0.98
Streptococcus anginosus-associated endogenous endophthalmitis mimicking fungal endophthalmitis. J Clin Microbiol (2005) 0.98
Cyclosporin A in the treatment of severe Behçet's uveitis. Br J Rheumatol (1987) 0.97
Plasma cleaning of dental instruments. J Hosp Infect (2004) 0.97
Ocular neuromyotonia. Br J Ophthalmol (1996) 0.96
Cerebral and retinal vascular changes in systemic lupus erythematosus. Ophthalmology (1985) 0.96
Experimental posterior uveitis. I: A clinical, angiographic, and pathological study. Br J Ophthalmol (1987) 0.96
Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol (1998) 0.95
Resolution of calcific band keratopathy after lowering elevated serum calcium in a patient with sarcoidosis. Br J Ophthalmol (1995) 0.95
Anterior visual system involvement in non-Hodgkin's lymphoma. Br J Ophthalmol (1993) 0.94
Ptosis and supranuclear downgaze paralysis. Neurology (1989) 0.94
Retinal vasculitis. Postgrad Med J (1988) 0.93
Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis. Clin Exp Immunol (1994) 0.93
MIC-A allele profiles and HLA class I associations in Behçet's disease. Immunogenetics (1999) 0.93
Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol (1998) 0.93
Ladies with Leber's hereditary optic neuropathy: an atypical disease. Eur J Ophthalmol (2003) 0.93
Serpiginous choroiditis: an unusual presentation of ocular sarcoidosis. Br J Ophthalmol (1994) 0.91
Tuberculosis presenting as retinal vasculitis. J R Soc Med (1988) 0.91
The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis. Eye (Lond) (1994) 0.90
Systematic review of ethnic variation in the phenotype of Behcet's disease. Scand J Rheumatol (2007) 0.90
Systemic associations of retinal vasculitis. Int Ophthalmol Clin (1991) 0.89
Macular ischaemia in posterior uveitis. Eye (Lond) (1993) 0.89
Endogenous Candida endophthalmitis with no apparent predisposing factors. Eye (Lond) (1998) 0.89
Choroidal abnormalities in birdshot chorioretinopathy: an indocyanine green angiography study. Eye (Lond) (1997) 0.88
The matrix metalloproteinase inhibitor BB-1101 prevents experimental autoimmune uveoretinitis (EAU). Clin Exp Immunol (1999) 0.88
Steroid prophylaxis in eyes with uveitis undergoing phacoemulsification. Br J Ophthalmol (2004) 0.88
Intercellular adhesion molecule-1 gene polymorphisms in Behçet's disease. Eur J Immunogenet (2000) 0.87
Optic neuropathy preceding acute retinal necrosis in acquired immunodeficiency syndrome. Arch Ophthalmol (1996) 0.87
Behçet's disease in patients of west African and Afro-Caribbean origin. Br J Ophthalmol (2003) 0.86
Tuberculous orbital apex syndromes. Br J Ophthalmol (2008) 0.86
Visual outcome of patients with idiopathic ischaemic and non-ischaemic retinal vasculitis. Eye (Lond) (1996) 0.86
Are cytokine gene polymorphisms associated with outcome in patients with idiopathic intermediate uveitis in the United Kingdom? Br J Ophthalmol (2005) 0.86
Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens (2004) 0.86
Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet's disease in Caucasian patients. Tissue Antigens (2005) 0.85
The effect of Toxoplasma gondii infection on expression of chemokines by rat retinal vascular endothelial cells. J Neuroimmunol (2004) 0.85
Neovascularisation associated with posterior uveitis. Br J Ophthalmol (1987) 0.85